Cargando…

Erratum for Two-year Outcomes of Infliximab Discontinuation in Patients with Rheumatoid Arthritis: A Retrospective Analysis from a Single Center

Detalles Bibliográficos
Autores principales: Takai, Chinatsu, Ito, Satoshi, Kobayashi, Daisuke, Nemoto, Tetsuya, Lee, Hyunho, Abe, Asami, Otani, Hiroshi, Nakazono, Kiyoshi, Murasawa, Akira, Ishikawa, Hajime
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Japanese Society of Internal Medicine 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8170242/
https://www.ncbi.nlm.nih.gov/pubmed/33952815
http://dx.doi.org/10.2169/internalmedicine.E002-21
_version_ 1783702198352347136
author Takai, Chinatsu
Ito, Satoshi
Kobayashi, Daisuke
Nemoto, Tetsuya
Lee, Hyunho
Abe, Asami
Otani, Hiroshi
Nakazono, Kiyoshi
Murasawa, Akira
Ishikawa, Hajime
author_facet Takai, Chinatsu
Ito, Satoshi
Kobayashi, Daisuke
Nemoto, Tetsuya
Lee, Hyunho
Abe, Asami
Otani, Hiroshi
Nakazono, Kiyoshi
Murasawa, Akira
Ishikawa, Hajime
author_sort Takai, Chinatsu
collection PubMed
description
format Online
Article
Text
id pubmed-8170242
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher The Japanese Society of Internal Medicine
record_format MEDLINE/PubMed
spelling pubmed-81702422021-06-11 Erratum for Two-year Outcomes of Infliximab Discontinuation in Patients with Rheumatoid Arthritis: A Retrospective Analysis from a Single Center Takai, Chinatsu Ito, Satoshi Kobayashi, Daisuke Nemoto, Tetsuya Lee, Hyunho Abe, Asami Otani, Hiroshi Nakazono, Kiyoshi Murasawa, Akira Ishikawa, Hajime Intern Med Erratum The Japanese Society of Internal Medicine 2021-05-01 2021-05-01 /pmc/articles/PMC8170242/ /pubmed/33952815 http://dx.doi.org/10.2169/internalmedicine.E002-21 Text en Copyright © 2021 by The Japanese Society of Internal Medicine https://creativecommons.org/licenses/by-nc-nd/4.0/The Internal Medicine is an Open Access journal distributed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License. To view the details of this license, please visit (https://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Erratum
Takai, Chinatsu
Ito, Satoshi
Kobayashi, Daisuke
Nemoto, Tetsuya
Lee, Hyunho
Abe, Asami
Otani, Hiroshi
Nakazono, Kiyoshi
Murasawa, Akira
Ishikawa, Hajime
Erratum for Two-year Outcomes of Infliximab Discontinuation in Patients with Rheumatoid Arthritis: A Retrospective Analysis from a Single Center
title Erratum for Two-year Outcomes of Infliximab Discontinuation in Patients with Rheumatoid Arthritis: A Retrospective Analysis from a Single Center
title_full Erratum for Two-year Outcomes of Infliximab Discontinuation in Patients with Rheumatoid Arthritis: A Retrospective Analysis from a Single Center
title_fullStr Erratum for Two-year Outcomes of Infliximab Discontinuation in Patients with Rheumatoid Arthritis: A Retrospective Analysis from a Single Center
title_full_unstemmed Erratum for Two-year Outcomes of Infliximab Discontinuation in Patients with Rheumatoid Arthritis: A Retrospective Analysis from a Single Center
title_short Erratum for Two-year Outcomes of Infliximab Discontinuation in Patients with Rheumatoid Arthritis: A Retrospective Analysis from a Single Center
title_sort erratum for two-year outcomes of infliximab discontinuation in patients with rheumatoid arthritis: a retrospective analysis from a single center
topic Erratum
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8170242/
https://www.ncbi.nlm.nih.gov/pubmed/33952815
http://dx.doi.org/10.2169/internalmedicine.E002-21
work_keys_str_mv AT takaichinatsu erratumfortwoyearoutcomesofinfliximabdiscontinuationinpatientswithrheumatoidarthritisaretrospectiveanalysisfromasinglecenter
AT itosatoshi erratumfortwoyearoutcomesofinfliximabdiscontinuationinpatientswithrheumatoidarthritisaretrospectiveanalysisfromasinglecenter
AT kobayashidaisuke erratumfortwoyearoutcomesofinfliximabdiscontinuationinpatientswithrheumatoidarthritisaretrospectiveanalysisfromasinglecenter
AT nemototetsuya erratumfortwoyearoutcomesofinfliximabdiscontinuationinpatientswithrheumatoidarthritisaretrospectiveanalysisfromasinglecenter
AT leehyunho erratumfortwoyearoutcomesofinfliximabdiscontinuationinpatientswithrheumatoidarthritisaretrospectiveanalysisfromasinglecenter
AT abeasami erratumfortwoyearoutcomesofinfliximabdiscontinuationinpatientswithrheumatoidarthritisaretrospectiveanalysisfromasinglecenter
AT otanihiroshi erratumfortwoyearoutcomesofinfliximabdiscontinuationinpatientswithrheumatoidarthritisaretrospectiveanalysisfromasinglecenter
AT nakazonokiyoshi erratumfortwoyearoutcomesofinfliximabdiscontinuationinpatientswithrheumatoidarthritisaretrospectiveanalysisfromasinglecenter
AT murasawaakira erratumfortwoyearoutcomesofinfliximabdiscontinuationinpatientswithrheumatoidarthritisaretrospectiveanalysisfromasinglecenter
AT ishikawahajime erratumfortwoyearoutcomesofinfliximabdiscontinuationinpatientswithrheumatoidarthritisaretrospectiveanalysisfromasinglecenter